norfloxacin has been researched along with Bile Duct Obstruction in 4 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrioz, T | 1 |
Ingrand, P | 2 |
Besson, I | 1 |
de Ledinghen, V | 2 |
Silvain, C | 1 |
Beauchant, M | 2 |
Wilcox, MH | 1 |
Lucena, MI | 1 |
Andrade, RJ | 1 |
Sanchez-Martinez, H | 1 |
Perez-Serrano, JM | 1 |
Gomez-Outes, A | 1 |
Person, B | 1 |
Legoux, JL | 1 |
Le Sidaner, A | 1 |
Desaint, B | 1 |
Greef, M | 1 |
Moesch, C | 1 |
Grollier, G | 1 |
Sautereau, D | 1 |
1 review available for norfloxacin and Bile Duct Obstruction
Article | Year |
---|---|
Norfloxacin-induced cholestatic jaundice.
Topics: Aged; Anti-Infective Agents; Cholestasis; Humans; Male; Norfloxacin; Urinary Tract Infections | 1998 |
2 trials available for norfloxacin and Bile Duct Obstruction
Article | Year |
---|---|
Randomised trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin.
Topics: Administration, Oral; Bile Ducts; Cholestasis; Constriction, Pathologic; Drug Therapy, Combination; | 1994 |
Prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin: a multicenter randomized trial.
Topics: Aged; Anti-Infective Agents; Cholagogues and Choleretics; Cholestasis; Female; Humans; Male; Norflox | 2000 |
1 other study available for norfloxacin and Bile Duct Obstruction
Article | Year |
---|---|
Preventing biliary stent occlusion.
Topics: Bacterial Infections; Cholestasis; Drug Therapy, Combination; Humans; Norfloxacin; Stents; Ursodeoxy | 1994 |